Philips gets FDA nod for rad therapy planning module

Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Pinnacle3 proton treatment planning module.

The proton module is fully integrated into the Pinnacle³ planning system for radiation therapy, and it enables users to plan either photon- or proton-based radiation therapy, Philips said.

Page 1 of 462
Next Page